Hing C. Wong
Chief Executive Officer at HCW Biologics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: HCW Biologics Inc., 3 years.
HCW Biologics Inc.
Director · Chief Executive Officer
Chief executive roles
HCW Biologics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | HCW Biologics Inc. | Open-market purchase | +23,210 | $2.59 | $59,998 |
| May 22, 2026 | HCW Biologics Inc. | Open-market purchase | +113,879 | $1.41 | $160,569 |
| May 16, 2025 | HCW Biologics Inc. | Open-market purchase | +8,054 | $7.45 | $60,002 |
| May 8, 2025 | HCW Biologics Inc. | Open-market purchase | +92,500 | $26.00 | $2,405,000 |
| Feb 20, 2024 | HCW Biologics Inc. | Grant or award | +739,288 | $1.40 | $1,035,003 |
| Sep 14, 2023 | HCW Biologics Inc. | Open-market purchase | +1,800 | $2.08 | $3,744 |
| Jun 2, 2023 | HCW Biologics Inc. | Open-market purchase | +800 | $1.54 | $1,232 |
| Jun 1, 2023 | HCW Biologics Inc. | Open-market purchase | +800 | $1.62 | $1,296 |
| May 31, 2023 | HCW Biologics Inc. | Open-market purchase | +2,000 | $1.55 | $3,100 |
| May 30, 2023 | HCW Biologics Inc. | Open-market purchase | +3,000 | $1.55 | $4,650 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.